» Articles » PMID: 26462838

An Integrative Transcriptomic Analysis Reveals P53 Regulated MiRNA, MRNA, and LncRNA Networks in Nasopharyngeal Carcinoma

Overview
Journal Tumour Biol
Publisher Sage Publications
Specialty Oncology
Date 2015 Oct 15
PMID 26462838
Citations 51
Authors
Affiliations
Soon will be listed here.
Abstract

It has been reported that p53 dysfunction is closely related to the carcinogenesis of nasopharyngeal carcinoma (NPC). Recently, an increasing body of evidence has indicated that microRNAs (miRNAs) and long noncoding RNAs (lncRNAs) participate in p53-associated signaling pathways and, in addition to mRNAs, form a complex regulation network to promote tumor occurrence and progression. The aim of this study was to elucidate the p53-regulated miRNAs, mRNAs, and lncRNAs and their regulating networks in NPC. Firstly, we overexpressed p53 in the NPC cell line HNE2 and performed transcriptomic gene expression profiling (GEP) analysis, which included miRNAs, mRNAs, and lncRNAs, using microarray technology at 0, 12, 24, and 48 h after transfection. There were 38 miRNAs (33 upregulated and 5 downregulated), 2107 mRNAs (296 upregulated and 1811 downregulated), and 1190 lncRNAs (133 upregulated and 1057 downregulated) that were significantly dysregulated by p53. Some of the dysregulated molecules were confirmed by quantitative real-time polymerase chain reaction (qRT-PCR). Then, we integrated previously published miRNAs, mRNAs, and lncRNAs GEP datasets from NPC biopsies to investigate the expression of these p53 regulated molecules and found that 7 miRNAs, 218 mRNAs, and 101 lncRNAs regulated by p53 were also differentially expressed in NPC tissues. Finally, p53-regulated miRNA, mRNA, and lncRNA networks were constructed using bioinformatics methods. These miRNAs, mRNAs, and lncRNAs may participate in p53 downstream signaling pathways and play important roles in the carcinogenesis of NPC. Thorough investigations of their biological functions and regulating relationships will provide a novel view of the p53 signaling pathway, and the restoration of p53 functioning or its downstream gene regulating network is potentially of great value in treating NPC patients.

Citing Articles

Atomic Force Microscopy: A Versatile Tool in Cancer Research.

Persano F, Parodi A, Pallaeva T, Kolesova E, Zamyatnin Jr A, Pokrovsky V Cancers (Basel). 2025; 17(5).

PMID: 40075706 PMC: 11899184. DOI: 10.3390/cancers17050858.


LncRNA MIR100HG Promotes Cell Proliferation in Nasopharyngeal Carcinoma by Targeting miR-136-5p/IL-6 Axis.

Huang X, Zhong H, Cai Y Mol Biotechnol. 2024; 66(5):1279-1289.

PMID: 38278928 DOI: 10.1007/s12033-023-01028-y.


Construction of a lncRNA-mRNA Co-Expression Network for Nasopharyngeal Carcinoma.

Fan C, Xiong F, Tang Y, Li P, Zhu K, Mo Y Front Oncol. 2022; 12:809760.

PMID: 35875165 PMC: 9302896. DOI: 10.3389/fonc.2022.809760.


Differentially Expressed Genes in Nasopharyngeal Carcinoma Tissues and Their Correlation with Recurrence and Metastasis of Nasopharyngeal Carcinoma.

Yue H, Zhu H, Luo D, Du Q, Xie Y, Huang S Comput Math Methods Med. 2022; 2022:1941412.

PMID: 35509856 PMC: 9061011. DOI: 10.1155/2022/1941412.


The emerging landscape of long non-coding RNAs in hepatocellular carcinoma.

Zhu Y, Xu G, Han C, Xing G Int J Clin Exp Pathol. 2021; 14(9):920-937.

PMID: 34646411 PMC: 8493264.


References
1.
Liu N, Chen N, Cui R, Li W, Li Y, Wei R . Prognostic value of a microRNA signature in nasopharyngeal carcinoma: a microRNA expression analysis. Lancet Oncol. 2012; 13(6):633-41. DOI: 10.1016/S1470-2045(12)70102-X. View

2.
Pan J, Zhang S, Chen C, Xiao S, Sun Y, Liu C . Effect of recombinant adenovirus-p53 combined with radiotherapy on long-term prognosis of advanced nasopharyngeal carcinoma. J Clin Oncol. 2008; 27(5):799-804. DOI: 10.1200/JCO.2008.18.9670. View

3.
Cai B, Wu Z, Liao K, Zhang S . Long noncoding RNA HOTAIR can serve as a common molecular marker for lymph node metastasis: a meta-analysis. Tumour Biol. 2014; 35(9):8445-50. DOI: 10.1007/s13277-014-2311-4. View

4.
Lin J, Huo R, Xiao L, Zhu X, Xie J, Sun S . A novel p53/microRNA-22/Cyr61 axis in synovial cells regulates inflammation in rheumatoid arthritis. Arthritis Rheumatol. 2014; 66(1):49-59. DOI: 10.1002/art.38142. View

5.
Guo H, Ingolia N, Weissman J, Bartel D . Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature. 2010; 466(7308):835-40. PMC: 2990499. DOI: 10.1038/nature09267. View